Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

DiNardo

Showing results (1041-1050 of 1,482) with videos related to

Pageof 149
Sort By:
Blood|December 23, 2016
Long-term outcome of acute promyelocytic leukemia treated with all-<i>trans</i>-retinoic acid, arsenic trioxide, and gemtuzumabYasmin Abaza, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Cancer|August 9, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutationSankalp Arora, Wei-Ying Jen, Musa Yilmaz, et al.
BMC Infectious Diseases|February 21, 2024
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluationLucia Carratala-Castro, Willy Ssengooba, Alex Kay, et al.
Leukemia|March 25, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trialsG Montalban-Bravo, X Huang, K Naqvi, et al.
Frontiers in Oncology|February 15, 2021
Next-Generation Sequencing of <i>DDX41</i> in Myeloid Neoplasms Leads to Increased Detection of Germline AlterationsSarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.
Haematologica|December 12, 2024
Clinical interrogation of <i>TP53</i> aberrations and its impact on survival in patients with myeloid neoplasmsJayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, et al.
The Lancet. Haematology|December 15, 2018
Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trialNicholas J Short, Hagop M Kantarjian, Sanam Loghavi, et al.
Elife|February 16, 2023
Emergent dynamics of adult stem cell lineages from single nucleus and single cell RNA-Seq of <i>Drosophila</i> testesAmelie A Raz, Gabriela S Vida, Sarah R Stern, et al.
British Journal of Haematology|September 22, 2025
MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemiaWei-Ying Jen, Guilin Tang, Eitan Kugler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative AnalysisNaval Daver, Jayastu Senapati, Hagop M Kantarjian, et al.
Pageof 149

Showing results (1041-1050 of 1,482) with videos related to

Sort By:
Pageof 149
Blood|December 23, 2016
Long-term outcome of acute promyelocytic leukemia treated with all-<i>trans</i>-retinoic acid, arsenic trioxide, and gemtuzumabYasmin Abaza, Hagop Kantarjian, Guillermo Garcia-Manero, et al.
Cancer|August 9, 2025
Outcomes of patients with newly diagnosed acute myeloid leukemia with FLT3-tyrosine kinase domain mutations: Prognostic implications of NPM1 co-mutationSankalp Arora, Wei-Ying Jen, Musa Yilmaz, et al.
BMC Infectious Diseases|February 21, 2024
A stool based qPCR for the diagnosis of TB in children and people living with HIV in Uganda, Eswatini and Mozambique (Stool4TB): a protocol for a multicenter diagnostic evaluationLucia Carratala-Castro, Willy Ssengooba, Alex Kay, et al.
Leukemia|March 25, 2017
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trialsG Montalban-Bravo, X Huang, K Naqvi, et al.
Frontiers in Oncology|February 15, 2021
Next-Generation Sequencing of <i>DDX41</i> in Myeloid Neoplasms Leads to Increased Detection of Germline AlterationsSarah A Bannon, Mark J Routbort, Guillermo Montalban-Bravo, et al.
Haematologica|December 12, 2024
Clinical interrogation of <i>TP53</i> aberrations and its impact on survival in patients with myeloid neoplasmsJayastu Senapati, Sanam Loghavi, Guillermo Garcia-Manero, et al.
The Lancet. Haematology|December 15, 2018
Treatment with a 5-day versus a 10-day schedule of decitabine in older patients with newly diagnosed acute myeloid leukaemia: a randomised phase 2 trialNicholas J Short, Hagop M Kantarjian, Sanam Loghavi, et al.
Elife|February 16, 2023
Emergent dynamics of adult stem cell lineages from single nucleus and single cell RNA-Seq of <i>Drosophila</i> testesAmelie A Raz, Gabriela S Vida, Sarah R Stern, et al.
British Journal of Haematology|September 22, 2025
MECOM fusion partner and bone marrow blast percentage influence outcomes of patients with MECOM rearranged acute myeloid leukaemiaWei-Ying Jen, Guilin Tang, Eitan Kugler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2025
Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed Refractory Acute Myeloid Leukemia: Phase Ib/II Study and Correlative AnalysisNaval Daver, Jayastu Senapati, Hagop M Kantarjian, et al.
Pageof 149